Company intelligence / Profile preview

Innate Pharma

Marseille, Provence-Alpes-Côte d’Azur, Franceinnate-pharma.com ↗
Ownership
Public · IPHA
Employees
~168
Development stage
Phase 3
01

Overview

Innate Pharma has a diversified clinical pipeline focused on immunotherapies for cancer. Lead assets include lacutamab in advanced cutaneous and peripheral T-cell lymphomas; monalizumab with AstraZeneca in NSCLC; several multi-specific NK cell engagers from the ANKET® platform targeting hematologic malignancies and solid tumors; and the ADC IPH4502 targeting Nectin‑4-expressing solid tumors now in Phase 1 trials. Early data show promise for efficacy across multiple tumor types with differentiated mechanisms of action.

Therapeutic areas
OncologyHematology
Modalities
Monoclonal antibodies (mAbs)Multi-specific NK cell engagersAntibody-drug conjugates (ADCs)
Industry
Biotech
02

Drug pipeline

15 assets

IPH5201

2

14 more assets in the full pipeline.

Request access →
03

Partnerships

AstraZenecaSanofiResearch institutions/universities
04

Financials

Market cap
$192.5M
Total revenue
$-2.1M
Enterprise value
$180.8M

Beyond the preview

Go deeper on Innate Pharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Innate Pharma.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call